Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin-C Are Sensitive Markers of Renal Injury in Patients with Multiple Myeloma,

Evangelos Terpos, Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Maria Gkotzamanidou, Dimitrios Christoulas, Evangelos Eleutherakis-Papaiakovou, Alexandra Margeli, Magdalini Migkou, Maria Gavriatopoulou, Maria Roussou, Ioannis Papassotiriou, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 3918.

https://doi.org/10.1182/blood.V118.21.3918.3918

Published: 2011

Journal Articles

Diffuse Pattern of Bone Marrow Involvement in MRI Is Associated with High Risk Cytogenetics and Poor Outcome in Newly Diagnosed, Symptomatic Patients with Multiple Myeloma,

Lia A Moulopoulos, Efstathios Kastritis, Evangelos Terpos, Maria Gkotzamanidou, Maria Roussou, Andreas Koureas, Magdalini Migkou, Maria Gavriatopoulou, Dimitra Gika, Vasilios Koutoulidis, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 3920.

https://doi.org/10.1182/blood.V118.21.3920.3920

Published: 2011

Journal Articles

Circulating Periostin Is Elevated in Patients with Multiple Myeloma and Correlates with Advanced Disease Features and High Bone Resorption,

Evangelos Terpos, Dimitrios Christoulas, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Athanasios Papatheodorou, Anastasia Pouli, Efstathios Kastritis, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 3922.

https://doi.org/10.1182/blood.V118.21.3922.3922

Published: 2011

Journal Articles

Extensive Bone Marrow Infiltration and Abnormal Free Light Chain Ratio Identifies Patients with Smoldering Myeloma At High Risk for Progression to Symptomatic Disease,

Efstathios Kastritis, Lia A Moulopoulos, Maria Gkotzamanidou, Dimitra Gika, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 3926.

https://doi.org/10.1182/blood.V118.21.3926.3926

Published: 2011

Journal Articles

Update on a Phase III Study of Panobinostat with Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: PANORAMA 1,

Blood (2011) 118 (21): 3976.

https://doi.org/10.1182/blood.V118.21.3976.3976

Published: 2011

Journal Articles

Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Displays Treatment Characteristics Favourable to Global Quality of Life in Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years,

Meletios Athanasios Dimopoulos, MD, Antonio Palumbo, MD, Roman Hajek, MD, PhD, Martin Kropff, MD, Maria Teresa Petrucci, MD, Philip Lewis, PhD, Stefanie Millar, Jingshan Zhang, PhD, Jay Mei, MD, PhD, Michel Delforge, MD, PhD

Blood (2011) 118 (21): 3988.

https://doi.org/10.1182/blood.V118.21.3988.3988

Published: 2011

Journal Articles

Bone Involvement in Patients with Non-Neuronopathic Gaucher Disease Is Characterized by Increased Osteoclast Function Partially Due to High Circulating C-C Motif Ligand 3,

Veroniki Komninaka, Theodore Marinakis, Dimitrios Christoulas, Konstantina Repa, Dionysia Kolomodi, Maria Mitropoulou, Maria Gkotzamanidou, Athanasios Papatheodorou, Nikolaos Anagnostopoulos, Meletios Athanasios Dimopoulos, MD, Evangelos Terpos

Blood (2011) 118 (21): 3215.

https://doi.org/10.1182/blood.V118.21.3215.3215

Published: 2011

Journal Articles

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Evangelos Terpos, Meletios Athanasios Dimopoulos, MD, Stephanie Harel, MD, Francis K Buadi, M.D., Dimitrios Christoulas, Ersi Voskaridou, Efstathios Kastritis, Jean Paul Fermand, MD, Angela Dispenzieri, MD

Blood (2011) 118 (21): 806.

https://doi.org/10.1182/blood.V118.21.806.806

Published: 2011

Journal Articles

Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial

Meletios Athanasios Dimopoulos, MD, Sundar Jagannath, MD, Sung-Soo Yoon, MD, PhD, David S. Siegel, MD, PhD, Sagar Lonial, MD, Roman Hajek, MD, PhD, Thierry Facon, MD, Laura Rosiñol, MD, Hilary Anne Blacklock, MD, Hartmut Goldschmidt, MD, Vania Hungria, MD, Andrew Spencer, MD, Antonio Palumbo, MD, Donna E. Reece, MD, FRCPC, Thorsten Graef, MD, PhD, Jennifer Houp, Linda Sun, PhD, Joseph E. Eid, MD, Kenneth C. Anderson, MD

Blood (2011) 118 (21): 811.

https://doi.org/10.1182/blood.V118.21.811.811

Published: 2011

Journal Articles

Circulating Angiogenic Cytokines Are Elevated in Patients with Smoldering Myeloma; Implications Into Disease Biology

Maria Gkotzamanidou, Evangelos Terpos, Athanasios Papatheodorou, Evangelos Eleutherakis-Papaiakovou, Meletios Athanasios Dimopoulos, MD, Efstathios Kastritis

Blood (2011) 118 (21): 5059.

https://doi.org/10.1182/blood.V118.21.5059.5059

Published: 2011

Journal Articles

Bone Marrow Biopsy May Be Required During the Initial Evaluation of Individuals with Asymptomatic Monoclonal Gammopathy

Meletios Athanasios Dimopoulos, MD, Evangelos Terpos, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Maria Gavriatopoulou, Dimitrios Christoulas, Maria Roussou, Efstathios Kastritis

Blood (2011) 118 (21): 5067.

https://doi.org/10.1182/blood.V118.21.5067.5067

Published: 2011

Journal Articles

Low Circulating Mannan-Binding Leptin Levels Correlate with Increased Number of Febrile Episodes in Myeloma Patients Who Undergo High Dose Melphalan with Autologous Hematopoietic Stem Cell Transplantation and Do Not Receive Antibiotic Prophylaxis

Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Dimitrios Christoulas, Magdalini Migkou, Efstathios Kastritis, Maria Gkotzamanidou, Nikitas Nikitas, Efstathios Manios, Meletios Athanasios Dimopoulos, MD, Christos Papadimitriou

Blood (2011) 118 (21): 4457.

https://doi.org/10.1182/blood.V118.21.4457.4457

Published: 2011

Journal Articles

Mobilization of Autologous Peripheral Blood Stem Cells with Spectra Optia v5.0: A Single Center Experience with An Automatic Interface-Controlled Apheresis System

Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Efstathios Kastritis, Dimitrios Christoulas, Magdalini Migkou, Meletios Athanasios Dimopoulos, MD, Christos Papadimitriou

Blood (2011) 118 (21): 4396.

https://doi.org/10.1182/blood.V118.21.4396.4396

Published: 2011

Journal Articles

Prospective Evaluation of the Risk of Thromboembolic Complications in Patients Treated with Lenalidomide-based Therapy and Genetic Associations

Tina Bagratuni, Efstathios Kastritis, Maria Roussou, Dimitrios Christoulas, Efthimios Kostouros, Marianna Politou, Evangelos Terpos, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 2872.

https://doi.org/10.1182/blood.V118.21.2872.2872

Published: 2011

Journal Articles

Long-Term Outcomes and Safety of Continuous Lenalidomide Plus Dexamethasone (Len+Dex) Treatment in Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM)

Meletios Athanasios Dimopoulos, MD, Mohamad Hussein, MD, Arlene S Swern, PhD, Donna M. Weber, MD

Blood (2011) 118 (21): 2929.

https://doi.org/10.1182/blood.V118.21.2929.2929

Published: 2011

Journal Articles

Deletion 17p in Unselected Newly Diagnosed Symptomatic Patients with Multiple Myeloma

Efstathios Kastritis, Evangelos Terpos, Maria Gkotzamanidou, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios Christoulas, Dimitra Gika, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 5081.

https://doi.org/10.1182/blood.V118.21.5081.5081

Published: 2011

Journal Articles

Frequency and Prognostic Significance of Hypercalcemia in Patients with Multiple Myeloma: An Analysis of the Database of the Greek Myeloma Study Group

Efstathios Kastritis, Eirini Katodritou, Anastasia Pouli, Eleftheria Hatzimichael, Sosana Delimpasi, Eurydiki Michalis, Athanasios Zomas, Zafiris Kartasis, Agapi Parcharidou, Dimitra Gika, Panagiotis Repousis, Ekaterini Stefanoudaki, Argiris Symeonidis, Panayiotis Panayiotidis, Konstantinos Konstantopoulos, Evangelos Terpos, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 5083.

https://doi.org/10.1182/blood.V118.21.5083.5083

Published: 2011

Journal Articles

Clinical Features and Outcome of Newly Diagnosed, Symptomatic Patients with Multiple Myeloma ≥80 Years of Age: An Analysis of the Greek Myeloma Study Group

Meletios Athanasios Dimopoulos, MD, Efstathios Kastritis, Sosana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, Marie-Christine Kyrtsonis, Panagiotis Repousis, Maria Tsirogianni, MD, Zafiris Kartasis, Agapi Parcharidou, Michalis Michael, Eurydiki Michalis, Dimitra Gika, Argiris Symeonidis, Evangelos Terpos, Konstantinos Zervas

Blood (2011) 118 (21): 5084.

https://doi.org/10.1182/blood.V118.21.5084.5084

Published: 2011

Journal Articles

Characteristics and Clinical Course of Myeloma in Patients 40 Years of Age or Younger: A Study of the Greek Myeloma Study Group

Argiris Symeonidis, Efstathios Kastritis, Anastasia Sioni, Sosana Delimpasi, Eirini Katodritou, Eurydiki Michalis, Panagiotis Repousis, Zafiris Kartasis, Nora-Athina Viniou, Konstantinos Zervas, Evangelos Terpos, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 5085.

https://doi.org/10.1182/blood.V118.21.5085.5085

Published: 2011

Journal Articles

High Circulating Vascular Endothelial Growth Factor Receptor-1 Correlates with Increased Microvessel Density and Inferior Survival in Newly-Diagnosed Patients with Multiple Myeloma Who Receive Frontline Therapy with Novel Agent-Based Regimens

Gerasimos-Petros Papassotiriou, Evangelos Terpos, Efstathios Kastritis, Maria Gkotzamanidou, Filia Apostolakou, Evangelos Eleutherakis-Papaiakovou, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 5082.

https://doi.org/10.1182/blood.V118.21.5082.5082

Published: 2011

NARROW

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin-C Are Sensitive Markers of Renal Injury in Patients with Multiple Myeloma,

Diffuse Pattern of Bone Marrow Involvement in MRI Is Associated with High Risk Cytogenetics and Poor Outcome in Newly Diagnosed, Symptomatic Patients with Multiple Myeloma,

Circulating Periostin Is Elevated in Patients with Multiple Myeloma and Correlates with Advanced Disease Features and High Bone Resorption,

Extensive Bone Marrow Infiltration and Abnormal Free Light Chain Ratio Identifies Patients with Smoldering Myeloma At High Risk for Progression to Symptomatic Disease,

Update on a Phase III Study of Panobinostat with Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: PANORAMA 1,

Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Displays Treatment Characteristics Favourable to Global Quality of Life in Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years,

Bone Involvement in Patients with Non-Neuronopathic Gaucher Disease Is Characterized by Increased Osteoclast Function Partially Due to High Circulating C-C Motif Ligand 3,

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial

Circulating Angiogenic Cytokines Are Elevated in Patients with Smoldering Myeloma; Implications Into Disease Biology

Bone Marrow Biopsy May Be Required During the Initial Evaluation of Individuals with Asymptomatic Monoclonal Gammopathy

Low Circulating Mannan-Binding Leptin Levels Correlate with Increased Number of Febrile Episodes in Myeloma Patients Who Undergo High Dose Melphalan with Autologous Hematopoietic Stem Cell Transplantation and Do Not Receive Antibiotic Prophylaxis

Mobilization of Autologous Peripheral Blood Stem Cells with Spectra Optia v5.0: A Single Center Experience with An Automatic Interface-Controlled Apheresis System

Prospective Evaluation of the Risk of Thromboembolic Complications in Patients Treated with Lenalidomide-based Therapy and Genetic Associations

Long-Term Outcomes and Safety of Continuous Lenalidomide Plus Dexamethasone (Len+Dex) Treatment in Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM)

Deletion 17p in Unselected Newly Diagnosed Symptomatic Patients with Multiple Myeloma

Frequency and Prognostic Significance of Hypercalcemia in Patients with Multiple Myeloma: An Analysis of the Database of the Greek Myeloma Study Group

Clinical Features and Outcome of Newly Diagnosed, Symptomatic Patients with Multiple Myeloma ≥80 Years of Age: An Analysis of the Greek Myeloma Study Group

Characteristics and Clinical Course of Myeloma in Patients 40 Years of Age or Younger: A Study of the Greek Myeloma Study Group

High Circulating Vascular Endothelial Growth Factor Receptor-1 Correlates with Increased Microvessel Density and Inferior Survival in Newly-Diagnosed Patients with Multiple Myeloma Who Receive Frontline Therapy with Novel Agent-Based Regimens

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only